Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 1936 to 1950 of 7682 results

  1. Remimazolam for sedation for people having diagnostic or therapeutic procedures [ID3758]

    The topic was stopped after scoping, this means the topic will not proceed to a Technology Appraisal   ...

    Technology appraisal guidance
    Topic selection

  2. Masitinib with riluzole for treating amyotrophic lateral sclerosis ID6257

    In development [GID-TA11071] Expected publication date: TBC

    Technology appraisal guidance
    In development

  3. Kidney Cancer

    In development [GID-QS10186] Expected publication date: TBC

    Quality standard
    In development

  4. Blinatumomab with chemotherapy for consolidation treatment of Philadelphia-chromosome-negative CD19-positive B-precursor acute lymphoblastic leukaemia with no measurable residual disease TS ID 11991

    Awaiting development [GID-TA11518] Expected publication date: TBC

    Technology appraisal guidance
    Awaiting development

  5. Iodine (131I)–apamistamab for treating relapsed or refractory acute myeloid leukaemia before an allogeneic haematopoietic stem cell transplant [ID6355]

    In development [GID-TA11425] Expected publication date: TBC

    Technology appraisal guidance
    In development

  6. DCVax-L for treating glioblastoma [ID836]

    In development [GID-TA10143] Expected publication date: TBC

    Technology appraisal guidance
    In development

  7. Atezolizumab with cabozantinib for treating metastatic non-small-cell lung cancer after platinum-based chemotherapy and 1 PD-L1 checkpoint inhibitor TSID 11812

      Status ...

    Health technology evaluations
    Topic selection

  8. Tafasitamab with lenalidomide and rituximab for treating relapsed or refractory follicular or marginal zone lymphoma after 1 or more anti-CD20 treatments ID6413

    Awaiting development [GID-TA11488] Expected publication date: TBC

    Technology appraisal guidance
    Awaiting development

  9. Pembrolizumab with olaparib and chemoradiation for previously untreated limited-stage ID6412 small-cell lung cancer TS ID 11975

    Awaiting development [GID-TA11497] Expected publication date: TBC

    Technology appraisal guidance
    Awaiting development

  10. Implantable Vagus Nerve Stimulator in Heart Failure

    Register an interest in this interventional procedure   ...

    Interventional procedures guidance
    Topic selection

  11. Cutting blocks for total knee arthroplasty

    Register an interest in this interventional procedure   ...

    Interventional procedures guidance
    Topic selection

  12. Degradable surgical implant

    Register an interest in this interventional procedure NICE has been notified about this procedure and we are considering whether it fit...

    Interventional procedures guidance
    Topic selection

  13. Spineform Hemibridge endoscopic vertebral stapling to reduce curvature in the growing scoliotic spine in children

    Register an interest in this interventional procedure   ...

    Interventional procedures guidance
    Topic selection

  14. Autologous unmanipulated peripheral blood stem cell therapy for multiple sclerosis

    Register an interest in this interventional procedure NICE has been notified about the above procedure and considered it part of the In...

    Interventional procedures guidance
    Topic selection

  15. Peroral endoscopic myotomy (POEM) for achalasia

    Register an interest in this interventional procedure   ...

    Interventional procedures guidance
    Topic selection